Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"
- PMID: 37747952
- DOI: 10.1161/CIRCULATIONAHA.123.066276
Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"
Conflict of interest statement
Comment on
-
Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".Circulation. 2023 Sep 26;148(13):1058. doi: 10.1161/CIRCULATIONAHA.123.065391. Epub 2023 Sep 25. Circulation. 2023. PMID: 37747950 No abstract available.
-
Letter by Aldana-Bitar et al Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".Circulation. 2023 Sep 26;148(13):1057. doi: 10.1161/CIRCULATIONAHA.123.065198. Epub 2023 Sep 25. Circulation. 2023. PMID: 37747953 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
